Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: A narrative review

Por Elizarova, Svetlana, Galstyan, Gagik R, Wolffenbuttel, Bruce HR
Publicado no J Diabetes (2014)

Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey

Por Brod, Meryl, Galstyan, Gagik, Unnikrishnan, Ambika Gopalakrishnan, Harman-Boehm, Ilana, Prusty, Vinay, Lavalle, Fernando, McGill, Margaret, Murphy, Angela, Puchulu, Felix
Publicado no Diabetes Ther (2016)

Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysi...

Por Ahrén, Bo, Galstyan, Gagik, Gautier, Jean-Francois, Giorgino, Francesco, Gomez-Peralta, Fernando, Krebs, Michael, Nikonova, Elena, Stager, William, Vargas-Uricoechea, Hernando
Publicado no Diabetes Ther (2016)

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies

Por Pedersen‐Bjergaard, Ulrik, Alsifri, Saud, Aronson, Ronnie, Berković, Maja Cigrovski, Galstyan, Gagik, Gydesen, Helge, Lekdorf, Jesper Barner, Ludvik, Bernhard, Moberg, Erik, Ramachandran, Ambady, Khunti, Kamlesh
Publicado no Diabetes Obes Metab (2018)

Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the Lixi...

Por Davies, Melanie J., Russell‐Jones, David, Barber, Thomas M., Lavalle‐González, Fernando J., Galstyan, Gagik R., Zhu, Dalong, Baxter, Mike, Dessapt‐Baradez, Cecile, McCrimmon, Rory J.
Publicado no Diabetes Obes Metab (2019)